Journals / Kocaeli Tıp Dergisi / 2022 / Cilt: 11 - Sayı: 1

Effect of COVID-19 Pandemic on Anxiety in Rheumatology Patients Taking Immunosuppressive Drugs

İmmünsüpresif İlaç Kullanan Romatoloji Hastalarında COVID-19 Pandemisinin Anksiyete Üzerine Etkisi

Pages
180–190
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Female had more anxiety symptoms in both groups (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The purpose of this study was to determine the prevalence of anxiety due to Coronavirus disease-2019 (COVID-19) pandemic in patients with rheumatic and musculoskeletal diseases (RMDs) who used immunosuppressive drugs during the initial stage of the COVID-19 pandemic and to identify the risk and protective factors that cause anxiety.
📊
Key Findings & Data:Method: A total of 145 patients with RMDs who used regular immunosuppressive drugs and 95 healthy controls were included.
💡
Conclusion & Impact:Female had more anxiety symptoms in both groups (p
🔬Design:Survey & Empirical Study
📍Scope:2019 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: The purpose of this study was to determine the prevalence of anxiety due to Coronavirus disease-2019 (COVID-19) pandemic in patients with rheumatic and musculoskeletal diseases (RMDs) who used immunosuppressive drugs during the initial stage of the COVID-19 pandemic and to identify the risk and protective factors that cause anxiety. Method: A total of 145 patients with RMDs who used regular immunosuppressive drugs and 95 healthy controls were included. An anonymous survey comprising questions regarding the COVID-19 pandemic was used, and the Beck anxiety inventory (BAI). Results: About 42.1% patients reported that the epidemic caused concern due to the drug they were using, 33.8% rated their concerns as moderate and severe. According to the BAI scores, 16.5% patients had moderate to severe anxiety symptoms; and comparison of the groups showed that the anxiety level of the patient group was significantly higher (38.6% vs. 18.9%, p=0.001). Female had more anxiety symptoms in both groups (p

Özet

Giriş: : Bu çalışmanın amacı, Coronavirus hastalığı-2019 (COVID-19) salgınının ilk aşamasında romatizmal ve kas-iskelet sistemi hastalıkları (RMDs) olan ve immunsupresif ilaç kullanan hastalarda COVID-19 salgınına bağlı anksiyete yaygınlığını tespit etmek ve anksiyeteye sebep olan risk ve koruyucu faktörleri tanımlamaktır. Yöntem: 18 yaşından büyük, RMDs’i olan ve düzenli immunsupresif ilaç kullanan 145 hasta ve 95 sağlıklı kontrol çalışmaya dahil edildi. COVID-19 salgını ile ilgili soruları içeren anonim bir anket ve katılımcıların anksiyete düzeylerini ölçmek için Beck anksiyete envanteri (BAI) kullanıldı. Demografik veriler, mevcut RMDs’i, kullandığı immunsupresif ilaç, COVID-19 hakkında bilgi ve endişeler, COVID-19 hakkındaki bilgileri nereden öğrendiği gibi ek bilgiler toplandı. Bulgular: Hastaların %42,1’i kullandıkları ilaç nedeniyle salgının endişe yarattığını bildirdi ve hastaların %33,8’i endişelerini orta ve şiddetli olarak derecelendirdiler. Hastaların BAI skorları 4 (0-52) ve sağlıklı kontrollerin BAI skorları 3 (0-18) olarak saptandı. BAI skorlarına göre hastaların %16,5’i orta ile şiddetli anksiyete belirtileri göstermiştir. İmmunsupresif ilaç kullanan hastaların %38,6’sında anksiyete saptanırken kontrol grubunun %18,9’unda anksiyete mevcuttu. Gruplar karşılaştırıldığında hasta grubunun anksiyetesi anlamlı yüksek saptandı (p=0.001). Hasta ve kontrol gruplarında kadın cinsiyet daha fazla anksiyete belirtileri göstermektedir (p

🔖

Cite This Article

DURAN, T. İ., AÇIKGÖZ, S. B., GÜRBÜZ, C., UÇAR, A., BİLGE, G. Y., ÖZGEN, M. (2022). Effect of COVID-19 Pandemic on Anxiety in Rheumatology Patients Taking Immunosuppressive Drugs. Kocaeli Tıp Dergisi, Cilt: 11 - Sayı: 1, 180–190. https://ajindex.com/articles/574650

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Song J, Kang S, Choi SW, Seo KW, Lee S, So MW, et al. Coronavirus Disease 19 (COVID-19) complicated with pneumonia in a patient with rheumatoid arthritis receiving conventional disease-modifying antirheumatic drugs. Rheumatol Int. 2020;40(6):991-5
  2. Organization WH. Coronavirus disease 2019 (COVID-19): situation report, 51. 2020
  3. Wang C, Horby PW, Hayden FG, Gao GF. A novel coronavirus outbreak of global health concern. Lancet. 2020;395(10223):470-3
  4. Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. The Lancet. 2020;395(10223):507-13
  5. Nishiura H, Kobayashi T, Yang Y, Hayashi K, Miyama T, Kinoshita R, et al. The rate of underascertainment of novel coronavirus (2019-nCoV) infection: Estimation using Japanese passengers data on evacuation flights. Multidisciplinary Digital Publishing Institute; 2020
  6. Baud D, Qi X, Nielsen-Saines K, Musso D, Pomar L, Favre G. Real estimates of mortality following COVID-19 infection. The Lancet Infectious Diseases. 2020
  7. Hall RC, Hall RC, Chapman MJ. The 1995 Kikwit Ebola outbreak: lessons hospitals and physicians can apply to future viral epidemics. Gen Hosp Psychiatry. 2008;30(5):446-52
  8. Peng EY, Lee MB, Tsai ST, Yang CC, Morisky DE, Tsai LT, et al. Population-based postcrisis psychological distress: an example from the SARS outbreak in Taiwan. J Formos Med Assoc. 2010;109(7):524-32
  9. Organization WH. Mental health and psychosocial considerations during the COVID-19 outbreak, 18 March 2020. World Health Organization; 2020
  10. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet. 2020;395(10223):497-506
  11. Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. The Lancet. 2020;395(10224):565-74
  12. Rubin GJ, Wessely S. The psychological effects of quarantining a city. Bmj. 2020;368
  13. Wang C, Pan R, Wan X, Tan Y, Xu L, Ho CS, et al. Immediate psychological responses and associated factors during the initial stage of the 2019 coronavirus disease (COVID-19) epidemic among the general population in china. International Journal of Environmental Research and Public Health. 2020;17(5):1729
  14. Rheumatism TELA. EULAR Guidance for patients COVID-19 outbreak 2020 https